Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease

被引：1597
|
作者：
Mawuenyega, Kwasi G. [1 ]
Sigurdson, Wendy [1 ,2 ]
Ovod, Vitaliy [1 ]
Munsell, Ling [1 ]
Kasten, Tom [1 ]
Morris, John C. [1 ,2 ,3 ]
Yarasheski, Kevin E. [4 ]
Bateman, Randall J. [1 ,2 ,5 ]
机构：
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
来源：
SCIENCE | 2010年 / 330卷 / 6012期
关键词：
IN-VIVO;
D O I：
10.1126/science.1197623
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：1774 / 1774
页数：1
相关论文
共 50 条
  • [21] Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy
    Xin, Shu-Hui
    Tan, Lin
    Cao, Xipeng
    Yu, Jin-Tai
    Tan, Lan
    NEUROTOXICITY RESEARCH, 2018, 34 (03) : 733 - 748
  • [22] Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
    Shu-Hui Xin
    Lin Tan
    Xipeng Cao
    Jin-Tai Yu
    Lan Tan
    Neurotoxicity Research, 2018, 34 : 733 - 748
  • [23] Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
    Thal, Dietmar R.
    FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [24] Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease
    Cheng, Yuan
    He, Chen-Yang
    Tian, Ding-Yuan
    Chen, Si-Han
    Ren, Jun-Rong
    Sun, Hao-Lun
    Xu, Man-Yu
    Tan, Cheng-Rong
    Fan, Dong-Yu
    Jian, Jie-Ming
    Sun, Pu-Yang
    Zeng, Gui-Hua
    Shen, Ying-Ying
    Shi, An-Yu
    Jin, Wang-Sheng
    Bu, Xian-Le
    Liu, Hong-Ming
    Xu, Yu-Ming
    Wang, Jun
    Wang, Yan-Jiang
    ACTA NEUROPATHOLOGICA, 2023, 145 (06) : 717 - 731
  • [25] Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease
    Yuan Cheng
    Chen-Yang He
    Ding-Yuan Tian
    Si-Han Chen
    Jun-Rong Ren
    Hao-Lun Sun
    Man-Yu Xu
    Cheng-Rong Tan
    Dong-Yu Fan
    Jie-Ming Jian
    Pu-Yang Sun
    Gui-Hua Zeng
    Ying-Ying Shen
    An-Yu Shi
    Wang-Sheng Jin
    Xian-Le Bu
    Hong-Ming Liu
    Yu-Ming Xu
    Jun Wang
    Yan-Jiang Wang
    Acta Neuropathologica, 2023, 145 : 717 - 731
  • [26] Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer's disease?
    Yulug, Burak
    Hanoglu, Lutfu
    Kilic, Ertugrul
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2017, 71 (10) : 673 - 677
  • [27] Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
    Sagare, Abhay P.
    Bell, Robert D.
    Zlokovic, Berislav V.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 : S87 - S100
  • [28] Chemical-Driven Amyloid Clearance for Therapeutics and Diagnostics of Alzheimer's Disease
    Kim, Hye Yun
    Kim, Youngsoo
    ACCOUNTS OF CHEMICAL RESEARCH, 2024, 57 (22) : 3266 - 3276
  • [29] Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
    Adam Kline
    Alzheimer's Research & Therapy, 4
  • [30] Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression
    Huang, Xin
    Fowler, Chris
    Li, Yihan
    Li, Qiao-Xin
    Sun, Jiaqi
    Pan, Yijun
    Jin, Liang
    Perez, Keyla A.
    Dubois, Celine
    Lim, Yen Y.
    Drysdale, Candace
    Rumble, Rebecca L.
    Chinnery, Holly R.
    Rowe, Christopher C.
    Martins, Ralph N.
    Maruff, Paul
    Doecke, James D.
    Lin, Yong
    Belaidi, Abdel A.
    Barnham, Kevin J.
    Masters, Colin L.
    Gu, Ben J.
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345